# Qutope

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qutope

- Industry: Materials
- Headquarters: Daejeon, South Korea
- Website: www.qutope.com
- Total disclosed funding: $4M
- Latest round: Series A (Nov 19, 2024)
- Investors on record: 4

## About

Based in Daejeon, South Korea, and founded in 2021, Qutope, Inc. operates as a producer of carbon and oxygen isotopes used to diagnose various diseases including cancer. As of November 2023, the company is led by its CEO Jeong Do-young. In November 2024, Qutope, Inc. raised KRW 5 billion in series A funding led by new investor Company K Partners, with participation from other new investors SJ Investment Partners and E&Venture Partners.

Qutope's flagship products are Oxygen-18 Concentrated Waters, including variations in atom concentrations, tailored to meet diverse needs. Additionally, the company prepares two more products: one focusing on carbon-13 and another on carbon-12, with high atom concentrations.  

The company will use the funding in November 2024 for research and developing new isotope materials, as well as investing in facilities and equipment to establish a complete mass production system for oxygen-18 and carbon isotope materials.

## Funding rounds

- Series A, Nov 19, 2024, $3.6M — Company K Partners, SJ Investment Partners, E&Venture Partners
- Seed, Apr 27, 2022, $0.4M — Bluepoint Partners

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A
- SJ Investment Partners (https://capitalatlas.ai/funds/sj-investment-partners) — Series A
- E&Venture Partners (https://capitalatlas.ai/funds/e-venture-partners) — Series A